Purpose Healthy or unhealthy lifestyle behaviors are often adopted together. We aimed to investigate the combined effect of estrogen-related lifestyle factors on postmenopausal breast cancer risk. Methods Data from 27,153 women enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial were used. We created an estrogen-related lifestyle score (ERLS) by incorporating a previously developed measure of estrogenic diet, alcohol intake, body mass index (BMI), and physical activity. The scores ranged from 0 to 6 with alcohol and BMI accounting for higher weights than the other factors. To evaluate the preventive possibilities of a low estrogen-related lifestyle and to be consistent with other published lifestyle scores, higher scores were set to correspond with potentially lower estrogenic lifestyle. The association between the ERLS and incident breast cancer was examined using Cox proportional hazards models. Results Participants with an ERLS of 4 or ≥ 5 had a 23% (HR 0.77; 95% CI 0.67-0.89) and 34% (HR 0.66; 95% CI 0.56-0.78) lower risk of breast cancer, respectively, compared to those with an ERLS ≤ 2 after multivariable adjustment. Estimates were similar when restricting to invasive cases or estrogen receptor-positive subtypes. No single lifestyle component appeared to drive the association. Conclusions Our findings suggest that the combined effect of a lifestyle characterized by a low estrogenic diet, low alcohol consumption, low body weight, and high levels of physical activity are associated with a reduction in postmenopausal breast cancer risk, possibly through an influence on estrogen metabolism.
Introduction
In the US, an estimated 250,000 incident breast cancer cases were diagnosed in 2017, accounting for approximately 30% of cancer diagnoses in women, with the majority of cases occurring in postmenopausal women [1, 2] . Although many well-established risk factors for postmenopausal breast cancer have been identified, not all represent opportunities for primary prevention to lessen this burden.
There is evidence linking several lifestyle factors to the development of postmenopausal breast cancer [2, 3] . Both sides of the energy balance equation-excess intake in the form of adiposity and greater energy expenditure in the form of physical activity (PA)-show evidence of a positive and negative association with breast cancer, respectively [2, 4] . Consumption of alcohol increases breast cancer risk [2, 4] . Although evidence of a dietary association with breast cancer is less robust, it is still suggestive [5, 6] . Lifestyle factors often cluster together in individuals who adopt healthy or unhealthy lifestyles, so it can be advantageous to use a combined lifestyle score to quantify how much risk can be reduced, if any, through embracing a healthy lifestyle [7] . Several studies have used indices to assess lifestyle factors as one aggregate score and have consistently reported moderate inverse associations between a healthy lifestyle and breast cancer [8] [9] [10] [11] [12] [13] [14] [15] . Previous indices were based on adherence to cancer prevention guidelines [8, 11] , included behaviors specific to a study population [9] , or were simply based on what is thought to constitute healthy behaviors [10, 12] .
Consideration of a disease mechanism in the development of a lifestyle score may help elucidate stronger associations than previous studies. In the case of postmenopausal breast cancer, the influence of estrogen exposure on mammary carcinogenesis is well-documented [16] . Regarding modifiable behaviors, increased adiposity after menopause and consumption of alcohol are positively associated with estrogen [17] , whereas PA is inversely associated with estrogen [18] . Recent dietary patterns developed to correlate with estrogen levels were subsequently associated with postmenopausal breast cancer risk in some study populations [19, 20] , but not all [21] . One of those patterns, the estrogen-related dietary pattern (ERDP) developed by our group, was based on an estrogen profile that is specific to breast cancer risk: high unconjugated estradiol (E2) and a low ratio of 2-to 16-hydroxylated metabolites (2/16) [20] .
In the present analysis, we aimed to assess the relationship between a lifestyle score based on estrogen-related lifestyle factors and postmenopausal breast cancer risk. We created the estrogen-related lifestyle score (ERLS) using the ERDP, alcohol consumption, body mass index (BMI), and PA as scoring components, and examined associations with postmenopausal breast cancer. We hypothesized that higher ERLS scores, representative of a lower combined estrogenic effect of lifestyle factors, would be inversely associated with postmenopausal breast cancer, and that more substantial associations would be present for estrogen receptor-positive (ER+) cases, and among the strata of effect modifiers associated with lower estrogen exposure.
Methods
The Prostate, Lung, Colorectal & Ovarian Cancer Screening Trial (PLCO) is an initiative of the National Cancer Institute to examine the effects of screening on various cancer endpoints. Design and implementation have been described in detail elsewhere [22] . Briefly, recruitment of 76,685 men and 78,216 women aged 55-74 took place at 10 different screening centers across the United States between 1993 and 2001. Women in the screening arm participated in chest X-ray, flexible sigmoidoscopy, a CA-125 blood test, and transvaginal ultrasound. The current analyses used only data from women randomized to the intervention arm of the study (n = 39,104) who completed a dietary questionnaire (DQX) at baseline, because participants in the control arm completed a different dietary questionnaire 3 years post-baseline. The study population was limited to women who completed the baseline questionnaire, had a valid DQX (between 1st and 99th percentiles of energy intake, < 8 missing line items), and without a personal history of cancer (except for non-melanoma skin cancer) at baseline, bringing the sample to 28,438. Participants were further excluded if they had an extreme (< 15 or > 55 kg/m 2 ; n = 74) or missing (n = 179) BMI, did not have data on PA (n = 112), or if they did not contribute any person-time (n = 58). After excluding participants with missing covariate data (n = 862) the final analytic sample comprised 27,153 participants. A subsample of women within the screening arm of PLCO had estrogen metabolite (EM) data, measured by liquid chromatography-tandem mass spectrometry assay of serum samples collected at baseline. This subsample, used in the development of the ERDP, came from a nested case-control study [23] and comprised 386 controls and 250 confirmed breast cancer cases who were diagnosed > 2 years after blood sample donation. Seventeen women who were included in the development of the ERDP were excluded in the present analysis due to missing PA data.
Data collection
Eligible participants filled out a risk factor questionnaire at baseline. Participants self-reported their height and weight, which was used to calculate BMI. Dietary data were collected via the DQX, a 137-item food frequency questionnaire (FFQ) designed specifically for PLCO to assess typical frequency of intake over the past year. Nutrient and food intake amounts were calculated using US dietary data and the pyramid food group servings database from the US Department of Agriculture (USDA) [24] . Separate line items were included for beer, liquor, and wine which were used to calculate alcohol drinks per day. The DQX also contained a question on the number of hours per week spent performing vigorous PA, with the response categories of < 1, 1, 2, 3, and ≥ 4.
Calculation of ERLS scoring
A summary of the ERLS scoring is portrayed in Table 1 . The dietary component of the ERLS was characterized using previously described ERDP score [20] . Briefly, reduced rank regression modeling was performed to identify a dietary pattern that was associated with serum levels of unconjugated E2 and the 2/16 ratio in a nested case-control of 653 postmenopausal women. The newly developed ERDP is composed of non-whole/refined grains, tomatoes, cruciferous vegetables, cheese, fish/shellfish high in ω-3 fatty acids, franks/luncheon meats, nuts and seeds, other vegetables, fish/shellfish low in ω-3 fatty acids, yogurt, and coffee. Intakes of these food groups were centered and scaled, then multiplied by their corresponding model weights. The total ERDP score was calculated by summing over the weighted intakes. Higher ERDP scores are positively associated with unconjugated E2 and inversely associated with the 2/16 ratio. The dietary component of the ERLS score was based on the median ERDP score (− 0.0206419) for the analytic PLCO population. Women with a score greater than or equal to the median received a 0, as those diets are hypothesized to be positively associated with estrogen metabolism and breast cancer risk. Women with an ERDP score below the median received a 1.
Scoring parameters for the remaining ERLS components are similar to those outlined in the World Cancer Research Fund (WCRF) and American Institute for Cancer Research's (AICR) Second Expert Report, and the USDA's 2015 Dietary Guidelines for Americans [3, 25] . Due to the strength of evidence for associations between alcohol intake and obesity status with breast cancer risk, and evidence of an estrogenic effect [3] , these variables were given a stronger weight using a three-level variable rather than two-level variable in the scoring of the ERLS. For alcohol intake, women who abstained from drinking (0 drink/week) were scored a 2; women who consumed > 0-7 drinks/week were scored a 1; and those who consumed > 7 drinks/week were scored a 0. Women were scored a 2 if they were normal weight ). For PA, women who reported > 2 h/week of vigorous PA were considered active and scored a 1, and those who reported ≤ 2 h/week were scored a 0. The score for each of the four different ERLS components was summed. Women with the minimum score of 0 were hypothesized to have the largest risk profile from estrogen exposure, and those with a maximum of 6 were hypothesized to have the lowest combined risk profile from estrogen-related lifestyle factors.
Breast cancer ascertainment
Incident breast cancer cases through December 31, 2009 were identified through self-report via annually mailed follow-up questionnaires. Other sources of ascertainment included the National Death Index, physician reports, state cancer registries, and next of kin reports. Over 96% of PLCO cases were confirmed through hospital records [26] . In the analytic cohort, a total of 1568 incident breast cancer cases were confirmed. A supplemental form was implemented in 2007 to capture more detailed information about the diagnosis, including ER status. Data on ER status were available for 70% of cases. Breast cancer events of interest included total breast cancer cases (including in situ), invasive only cases, and ER subtypes.
Statistical approach
Pearson correlation coefficients were used to quantify the strength of the relationship between the ERLS and EMs in the subsample of women with data on EMs. Cox proportional hazards models were applied to analyze the relationship between the ERLS and incident breast cancer events, with person-time calculated from date of completed DQX to end of follow-up or event [27] . The proportional hazards assumption was evaluated using Martingale-based residuals and was not violated by exposure variables or covariates [28] . The ERLS was grouped as follows: ≤ 2 (referent group), 3, 4, or ≥ 5. The three lowest scores (0, 1, and 2) and the two highest scores (5 and 6) were combined into single categories due to low numbers of cases. The first category hypothetically represents lifestyles with a higher exposure to estrogen. The hazard ratio (HR) and 95% confidence intervals (CI) also were calculated for the continuous ERLS score variable, and the p value reported as a test for trend. The linearity of the continuous ERLS was evaluated and confirmed by plotting the log hazard rate against the continuous ERLS measure. Demographic factors of age (years), race/ ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, Asian, other), and study center (10 categories) were included in the multivariable-adjusted models, along with total energy intake (kcal/day) for their putative roles as confounders for breast cancer. The remaining covariates included in multivariable-adjusted models were chosen using stepwise model selection with entry/exit criteria of p = 0.2. Further adjustment for PMH use (current; former; never; unknown), family history of breast cancer (yes; no; unknown), education (less than high school; high school and some college; college degree; graduate degree), BMI at age 20 (kg/m 2 ), bilateral oophorectomy (yes; no), parity (6 categories), and age at menopause (5 categories) was included in the multivariable models. Age at first birth, age at menarche, oral contraceptive use, smoking status, and prior hysterectomy also were considered as potential confounders but were not included after performing the stepwise model selection, as they did not improve the model. Effect modification by baseline PMH use (yes; no) and parity (nulliparous; parous) was examined in stratified results, and by including an interaction term in the model. A competing risk model assessed a differential association for the ERLS on ER+ and ER− subtypes using a Wald test for heterogeneity in the stratified Lunn-McNeil approach [29] . In secondary analyses, we evaluated associations between individual ERLS components and postmenopausal breast cancer with additional adjustment for each of the ERLS components that were not the main independent variable of interest. Additionally, to evaluate if an observed association between the ERLS and postmenopausal breast cancer was primarily influenced by a single ERLS component, we removed the components one at a time from the total ERLS score to see if the estimate of association with breast cancer changed significantly. All statistical tests were two-sided at α = 0.05 and all analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC).
Results
The median age at baseline was 62, with an interquartile range (IQR) of 58-67. After a median follow-up time of 11.5 years (IQR 10.3-12.8), 1576 incident cases of breast cancer were reported, with 1261 of those cases being invasive and the remaining 315 cases being in situ. Among cases where ER status was ascertained, 1089 were ER+ and 187 were ER−. In our subsample of participants with EM data, the ERLS was moderately correlated with unconjugated E2 (r = − 0.33; p < 0.01) and the 2/16 ratio (r = 0.20; p < 0.01). The distribution of characteristics across ERLS categories for the full analytic cohort are shown in Table 2 .
In Cox models with varying levels of adjustment, participants in the highest ERLS category experienced the lowest risk of postmenopausal breast cancer compared to the lowest ERLS category (Table 3 Table 1) . Table 4 shows results from investigations of individual ERLS scoring components. In all models, the category that was associated with a score of 0, representative of higher estrogen exposure, was the referent. A modest reduction in risk was observed in participants with score of 1 for the ERDP (HR 0.92; 95% CI 0.83-1.02) and for those with a score of 1 for PA (HR 0.92; 95% CI 0.83-1.02). Significant reductions in risk were seen among individuals with an alcohol score of 2 (HR 0.79; 95% CI 0.66-0.95), or 1 (HR 0.83; 95% CI 0.72-0.95); and for individuals with a BMI score of 2 (HR 0.72; 95% CI 0.62-0.83), or 1 (HR 0.88; 95% CI 0.76-1.00). The estimates of association for the ERLS remained relatively unchanged after removing individual components one at a time (Supplementary Table 2 ).
Discussion
In this large prospective cohort study of postmenopausal women, our findings suggest that the combined effect of modifiable lifestyle factors, namely diet, alcohol intake, BMI, and PA, is associated with risk of postmenopausal breast cancer. Specifically, women who were consuming a diet with less estrogenic potential, less alcohol, had a lower BMI, and were engaging in more PA were at reduced risk for breast cancer compared to women with less healthy lifestyles. A 1-U increase in the ERLS towards the direction of a lifestyle that was hypothesized to have lower estrogen exposure was associated with a 11% reduction in risk. The ERLS was moderately correlated with two EMs thought to be important indicators of breast cancer risk in a subsample of women. However, the association between ERLS and breast cancer did not differ by ER subtypes. Considering the prominence of an estrogenic influence on the development of breast cancer, the ERLS was developed to characterize the combined effect of estrogen-related lifestyle factors. Other lifestyle components, such as smoking or breastfeeding, were omitted from the ERLS as evidence of an estrogenic disease mechanism is not substantial [30] . All individual components of the ERLS exhibited inverse associations with postmenopausal breast cancer in multivariable-adjusted models, but none of the estimates of association were larger than their combined effect in the ERLS. According to the WCRF/AICR 2017 Continuous Update Project (CUP) [4] , there is strong evidence of increasing risk of postmenopausal breast cancer with body fatness (represented by BMI in the ERLS), alcohol, and PA. Furthermore, in a prior PLCO investigation, a 1-U increase in ERDP scores was associated with a significant 9% increase in risk of developing postmenopausal breast cancer [20] . The association between ERLS and postmenopausal breast cancer remained significant, with relatively no attenuation, after individual ERLS components were removed from the total score. These results suggest that no single component of the ERLS drove the observed significant association of the total ERLS with breast cancer risk.
To the best of our knowledge, this was the first application of a lifestyle score with a focus on estrogen as the primary mechanistic pathway. Prior research on lifestyle scores and breast cancer in prospective studies have yielded similar results. An a priori healthy lifestyle index score (HLIS) based on diet, tobacco use, alcohol, PA, and BMI reported 21% lower risk of breast cancer (HR 0.79, 95% CI 0.73-0.85) among the most healthy group in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort [12] . When the HLIS was applied in the same cohort, but with a dietary modification to include fish, folate, glycemic index, and other breast cancer risk-specific dietary components, the estimate of the inverse association was slightly stronger (HR 0.74; 95% CI 0.66-0.83) [10] . The association was strongest for ER−/progesterone receptor (PR)− breast cancer (HR 0.60; 95% CI 0.40-0.90), but also significant for ER+/PR+ (HR 0.81; 95% CI 0.67-0.98), suggesting that non-estrogenic disease pathways may have played a role [10] . Also using data from EPIC, a lifestyle score was developed to evaluate conformity to the WCRF/AICR recommendations on body fatness, PA, energy dense foods and drinks, plant foods, animal foods, alcohol use, and breastfeeding. Compared to the lowest scores, all categories showed a significant inverse association with breast cancer, with the strongest association in those with greatest conformity to the prevention guidelines (HR 0.84; 95% CI 0.78-0.90) [8] . Conformity to WCRF/AICR recommendations has exhibited BMI body mass index, CI confidence interval, ER estrogen receptor, ERDP estrogen-related dietary pattern, ERLS estrogen-related lifestyle score, HS high school, PA physical activity, PMH postmenopausal hormone inverse associations with breast cancer risk in other populations [13] [14] [15] , as well, including the Iowa Women's Health Study where associations did not differ in the presence of non-modifiable risk factors for breast cancer [14] . Evidence from case-control studies have shown similar, but stronger associations. In a case-control study of Mexican women, those in the highest quintile of a healthy index composed of diet, PA, alcohol consumption, and tobacco smoking had 80% lower odds of developing postmenopausal breast cancer compared to the lowest quintile (odds ratio (OR) 0.20; 95% CI 0.11-0.37) [9] . Increasing scores for a lifestyle score focused on limiting red meat, cream, and cheese; consuming more white meat, fish, fruit, and vegetables; lower alcohol consumption; not smoking; higher PA; lower BMI; and longer cumulative duration of breastfeeding was associated with a reduction in risk among indigenous New Zealanders (OR 0.47; 95% CI 0.23-0.94), but not among non-indigenous participants (OR 0.86; 95% CI 0.67-1.11) [11] . Cases and controls may differentially report their behaviors in case-control studies, introducing the potential for recall bias which is a limitation when interpreting these results. The misclassification resulting from recall bias may explain why larger associations were observed among case-control studies There is evidence that high levels of circulating unconjugated E2 and a low 2/16 ratio may be representative of an estrogen profile that increases the risk of postmenopausal breast cancer [31] . In our subsample of women with EM data, the ERLS was inversely and positively correlated with unconjugated E2 and the 2/16 ratio, respectively. Additionally, each component of the ERLS has been associated with estrogen metabolism [17, 18, 20] . Therefore, it is plausible that the combined effect of these lifestyle behaviors on postmenopausal breast cancer risk works through an influence on estrogen metabolism. Dietary behaviors are known to influence the intestinal microbiota [32] , which can subsequently influence excretion or reabsorption of active estrogens [33] . Alcohol consumption may increase aromatase activity, promoting the conversion of testosterone into estrogen [34] . Adipose tissue is the largest source of endogenous estrogen in postmenopausal women [2] , and there is strong evidence for a positive linear association between adipose tissue and estrogen levels in postmenopausal women [35] . The inverse association between PA and estrogen may be a result of reducing adipose-derived estrogen, or possibly through increased levels of SHBG, limiting the amount of available estrogen in active tissues [4, 36] .
It also is possible that the observed inverse association between the ERLS and postmenopausal breast cancer was mediated through an influence on inflammatory mechanisms. Many components of the ERDP, such as coffee, vegetables, fiber, and animal products have been shown to exhibit either inverse or positive associations with inflammatory markers [37, 38] . Furthermore, the remaining components of the ERLS (BMI, alcohol, and PA) have been shown to influence systemic inflammation [39, 40] .
Some limitations should be considered. There is the potential for bias due to the selection of subjects, loss to follow-up, and measurement error. Although FFQs may not generate accurate estimates for absolute intakes of nutrients, they are useful for ranking individuals, and only food or food group (not nutrients) intakes were utilized in this study [41] . The use of BMI is an imperfect proxy for adiposity, and BMI values were derived from self-reported height and weight. However, a validation study in a similar U.S. population showed strong correlation between self-reported and measured weight [42] . Our ability to detect an association for ER− cases was limited due to low numbers, however, this was not an issue for ER+ cases. A limitation for the PLCO study population is the lack of racial/ethnic diversity. However, non-Hispanic White women experience the highest incidence of breast cancer in the US, so results are generalizable to this high-risk group. We were unable to evaluate the construct validity of the ERLS in an external study population by examining its association with EMs, however, the ERLS was significantly correlated with EMs in a subsample of 636 PLCO women with EM data.
There are many strengths to our analysis, as well. The use of a large, prospective cancer cohort provided adequate power to detect small associations with information on known risk factors to appropriately adjust for confounders. The inclusion of the ERDP and pre-identification of a plausible mechanistic pathway aided in making meaningful interpretations of our results. This was a novel approach to developing a lifestyle score that is disease-and mechanism-specific.
In conclusion, our findings suggest that modifiable lifestyle behaviors have a combined effect on postmenopausal breast cancer risk, possibly through an alteration of estrogen metabolism. A lifestyle that is characterized by consumption of a diet with low estrogenic potential, low alcohol consumption, a low BMI, and high levels of PA may help to lower the risk of developing breast cancer in postmenopausal women. A collective change in lifestyle is likely more influential than focusing on specific behaviors.
